jrnls.org logo
Submit

BROWSE ALL JOURNALS

SEE ALL 19 JOURNALS
Pharmacognosy CommunicationsNOW IN
Article

Huperzinea: Pharmacological and Therapeutic Potential

Shagun Dubey Upadhyay1★, Yusra Ahmad2, Rajesh Kumar Sharma3, Seema Kohli1★ Corresponding author

  1. 1Department of Pharmacy, Government Kalaniketan Polytechnic College, Jabalpur, Madhya Pradesh, INDIA.
  2. 2Faculty of Pharmacy, Uttarakhand Technical University, Dehradun, Uttarakhand, INDIA.
  3. 3College of Veterinary Science and Animal Husbandry, Nanaji Deshmukh University of Veterinary Science, Jabalpur, Madhya Pradesh, INDIA.

CORRESPONDENCE

Shagun Dubey Upadhyay

Department of Pharmacy, Government Kalaniketan Polytechnic College, Jabalpur, Madhya Pradesh, INDIA.

dubeyshagun25@gmail.com

Volume 10, Issue 4 · pp. 146–149 · PUBLISHED · DOI: 10.5530/pc.2020.4.31

View on PC original site ↗

ABSTRACT

Introduction: Huperzine A (HupA) is derived from a club moss (Huperzia serrata). It is a potent and reversible inhibitor of acetyl cholinesterase (AChE). Chemically, it is a sesquiterpene alkaloid. It has been used for the treatment of swelling, fever and blood disorders for centuries in China. Methodology: The literature available on Huperzine was thoroughly studied. It has shown much beneficial effect since ages. It is a established Nootropic agent and widely used in the treatment of Alzheimer’s disease. The plant has shown promising results in vivo and in vitro studies. Results and Conclusion: The present review highlights the pharmacological potential of Huperzine with its pharmacokinetic and pharmacokinetic studies and it’s rational for future prospective.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Upadhyay, S. D., Ahmad, Y., Sharma, R. K., & Kohli, S. (). Huperzinea: Pharmacological and Therapeutic Potential. Pharmacognosy Communications, 10(4), 146–149. https://doi.org/10.5530/pc.2020.4.31